These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34896217)

  • 1. Non-viral siRNA transfection of primary mesenchymal stromal cells (MSCs): Assessment of tyrosine-modified PEI and PPI efficacy and biocompatibility.
    Noske S; Karimov M; Hansen M; Zatula N; Ewe A; Aigner A
    Int J Pharm; 2022 Jan; 612():121359. PubMed ID: 34896217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI) Strongly Improves Efficacy of siRNA-Mediated Gene Knockdown.
    Noske S; Karimov M; Aigner A; Ewe A
    Nanomaterials (Basel); 2020 Sep; 10(9):. PubMed ID: 32927826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of tyrosine-modified low molecular weight branched and linear polyethylenimines for siRNA delivery.
    Kubczak M; Michlewska S; Karimov M; Ewe A; Aigner A; Bryszewska M; Ionov M
    Nanotoxicology; 2022; 16(9-10):867-882. PubMed ID: 36697400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unmodified and tyrosine-modified polyethylenimines as potential carriers for siRNA: Biophysical characterization and toxicity.
    Kubczak M; Michlewska S; Karimov M; Ewe A; Noske S; Aigner A; Bryszewska M; Ionov M
    Int J Pharm; 2022 Feb; 614():121468. PubMed ID: 35031413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel tyrosine-modified low molecular weight polyethylenimine (P10Y) for efficient siRNA delivery in vitro and in vivo.
    Ewe A; Przybylski S; Burkhardt J; Janke A; Appelhans D; Aigner A
    J Control Release; 2016 May; 230():13-25. PubMed ID: 27061141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo.
    Zhupanyn P; Ewe A; Büch T; Malek A; Rademacher P; Müller C; Reinert A; Jaimes Y; Aigner A
    J Control Release; 2020 Mar; 319():63-76. PubMed ID: 31866504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined disulfide cross-linking and tyrosine-modification of very low molecular weight linear PEI synergistically enhances transfection efficacies and improves biocompatibility.
    Karimov M; Appelhans D; Ewe A; Aigner A
    Eur J Pharm Biopharm; 2021 Apr; 161():56-65. PubMed ID: 33582186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine-modified linear PEIs for highly efficacious and biocompatible siRNA delivery in vitro and in vivo.
    Karimov M; Schulz M; Kahl T; Noske S; Kubczak M; Gockel I; Thieme R; Büch T; Reinert A; Ionov M; Bryszewska M; Franke H; Krügel U; Ewe A; Aigner A
    Nanomedicine; 2021 Aug; 36():102403. PubMed ID: 33932594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of GFP expression in human mesenchymal stem cells using quaternary polyplexes of siRNA-PEI with glycosaminoglycans and albumin.
    Herrera LC; Shastri VP
    Acta Biomater; 2019 Nov; 99():397-411. PubMed ID: 31541736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEG grafting of polyethylenimine (PEI) exerts different effects on DNA transfection and siRNA-induced gene targeting efficacy.
    Malek A; Czubayko F; Aigner A
    J Drug Target; 2008 Feb; 16(2):124-39. PubMed ID: 18274933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.
    Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A
    Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maltose- and maltotriose-modified, hyperbranched poly(ethylene imine)s (OM-PEIs): Physicochemical and biological properties of DNA and siRNA complexes.
    Höbel S; Loos A; Appelhans D; Schwarz S; Seidel J; Voit B; Aigner A
    J Control Release; 2011 Jan; 149(2):146-58. PubMed ID: 20946922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
    Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
    J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell type and transfection reagent-dependent effects on viability, cell content, cell cycle and inflammation of RNAi in human primary mesenchymal cells.
    Yang HY; Vonk LA; Licht R; van Boxtel AM; Bekkers JE; Kragten AH; Hein S; Varghese OP; Howard KA; Öner FC; Dhert WJ; Creemers LB
    Eur J Pharm Sci; 2014 Mar; 53():35-44. PubMed ID: 24345796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional quantum dot-siRNA nanoplexes to regulate chondrogenic differentiation of mesenchymal stem cells.
    Wu Y; Zhou B; Xu F; Wang X; Liu G; Zheng L; Zhao J; Zhang X
    Acta Biomater; 2016 Dec; 46():165-176. PubMed ID: 27615736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier.
    Wang J; Dou B; Bao Y
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():98-109. PubMed ID: 24268238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower-Molecular-Weight Chitosan-Treated Polyethyleneimine: a Practical Strategy For Gene Delivery to Mesenchymal Stem Cells.
    Liu M; Zhang L; Zhao Q; Jiang X; Wu L; Hu Y
    Cell Physiol Biochem; 2018; 50(4):1255-1269. PubMed ID: 30355922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric Nanoparticles Based on Tyrosine-Modified, Low Molecular Weight Polyethylenimines for siRNA Delivery.
    Ewe A; Noske S; Karimov M; Aigner A
    Pharmaceutics; 2019 Nov; 11(11):. PubMed ID: 31726756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model.
    Ewe A; Höbel S; Heine C; Merz L; Kallendrusch S; Bechmann I; Merz F; Franke H; Aigner A
    Drug Deliv Transl Res; 2017 Apr; 7(2):206-216. PubMed ID: 27334279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.